GlaxoSmithKline, better known as GSK, has launched a new web effort aimed at providing both information and inspiration for people with chronic obstructive pulmonary disease, in what the company says is arguably the most engaging platform in the marketplace.
The rollout of the new COPD.com goes beyond what was previously offered, certainly by GSK but possibly many others, according to Darielle Ruderman, senior director of repository consumer marketing for the North Carolina-based company.